Zydus Cadila gets USFDA Approval for Vardenafil Hydrochloride Tablets
Ahmedabad: Zydus Cadila has launched Vardenafil Hydrochloride Tablets, 2.5 mg, 5 mg, 10 mg and 20 mg in the US market upon receiving the final approval from the USFDA. Manufactured at the group’s formulations manufacturing facility at SEZ, the medication is indicated for the treatment of erectile dysfunction.
The group also received the final approval from the USFDA to market Ursodiol Tablets, 250
mg and 500 mg. It will be manufactured at the group’s formulations manufacturing facility at Baddi. It is indicated for the treatment of patients with primary biliary cirrhosis, a chronic disease in which the bile ducts in the liver are slowly destroyed.
The group now has 226 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.
The group also received the final approval from the USFDA to market Ursodiol Tablets, 250
mg and 500 mg. It will be manufactured at the group’s formulations manufacturing facility at Baddi. It is indicated for the treatment of patients with primary biliary cirrhosis, a chronic disease in which the bile ducts in the liver are slowly destroyed.
The group now has 226 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.
ANDAsbiliary cirrhosischronic diseaseerectile dysfunctionliverUrsodiol TabletsUSFDAvardenafil hydrochloridevardenafil hydrochloride tabletsZydus Cadila
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd